is bpc 157 tga approved australia Since January 2026, there have been six cases of acute liver toxicity associated with unapproved peptide products labelled Retatrutide in Australia. These toxic effects may be linked to a contaminant in the This is a joint statement
Description
MU, RKC, TAS, MS, SB and LS initiated the project, have assisted in developing the protocol and helped with implementation
Our primary goal is to provide maximum absorption

Always follow facility storage protocols during multi-dose usage

Specifications Compound: PT-141 Quantity: 10 mg Purity: 99% (HPLC Certified) Form: Lyophilized powder Appearance: White to off-white powder Solubility: Soluble in laboratory-grade sterile water COA: Included in product image gallery Intended Use This peptide analog is supplied strictly for in-vitro laboratory research

Want to Learn More about What We Do

This will reduce the risk of dehydration and help you balance your consumption